Home Healthcare Pharmaceuticals Long-Acting Injectables (LAIs) Market

Long-Acting Injectables (LAIs) Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecules, Biologics), By Route of Administration (Intramuscular, Subcutaneous), By Therapeutic Area (Central Nervous System Disorders, Infectious Diseases, Metabolic & Endocrine Disorders, Oncology, Autoimmune & Inflammatory Diseases, Other Therapeutic Areas), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Specialty Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 14, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
  7. North America Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  8. Europe Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. France
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  9. APAC Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. China
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. India
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  10. Middle East and Africa Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  11. LATAM Long-Acting Injectables (LAIs) Market Size Analysis
    1. Introduction
    2. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. Small Molecules
      2. Biologics
    3. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intramuscular
      2. Subcutaneous
    4. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
      1. Central Nervous System Disorders
      2. Infectious Diseases
      3. Metabolic & Endocrine Disorders
      4. Oncology
      5. Autoimmune & Inflammatory Diseases
      6. Other Therapeutic Areas
    5. Long-Acting Injectables (LAIs) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Specialty Pharmacies
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      4. Market Size & Forecast By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
  12. Competitive Landscape
    1. Long-Acting Injectables (LAIs) Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Johnson & Johnson (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Amgen Inc. (US)
    3. Pfizer Inc. (US)
    4. AbbVie Inc. (US)
    5. AstraZeneca PLC (UK)
    6. Sanofi S.A. (France)
    7. Novartis AG (Switzerland)
    8. Novo Nordisk A/S (Denmark)
    9. GSK plc (UK)
    10. Lilly (US)
    11. Gilead Sciences, Inc. (US)
    12. Teva Pharmaceutical Industries Ltd. (Israel)
    13. Otsuka Pharmaceutical Co., Ltd. (Japan)
    14. Reddy's Laboratories Ltd. (India)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.